Victor Ling

Victor Ling, OC OBC (林重慶; born 1943) is a Canadian researcher in the field of medicine. Ling's research focuses on drug resistance in cancer. He is best known for his discovery of P-glycoprotein, one of the proteins responsible for multidrug resistance.

Victor Ling
Born1943 (age 79–80)
Shanghai, China
NationalityCanadian
Alma materUniversity of Toronto
Known forDiscovery of P-glycoprotein
Chinese name
Traditional Chinese林重慶
Hanyu PinyinLín Chóngqìng
Teochew Peng'imLim5 Cong5-kêng3

Early life

Ling was born in Shanghai, China in 1943, and is of Teochew ancestry. He moved to Hong Kong with his family in 1949 and lived there until 1952, when they emigrated to Canada.[1][2] He graduated from North Toronto Collegiate in 1962. He received his bachelor's degree in 1966 from the University of Toronto and his PhD in 1969 from the University of British Columbia.

Career

Ling undertook post-doctoral training with Nobel laureate Fred Sanger at Cambridge University before returning to Toronto.[3] He is currently Assistant Dean of the Faculty of Medicine at the University of British Columbia and former Vice-President, Discovery at the BC Cancer Agency in Vancouver, British Columbia, as well as the President and Scientific Director of the Terry Fox Research Institute.

Honours

References
  1. "加拿大华裔癌症专家林重庆获颁'加拿大勋章'". China News. 17 May 2009. Retrieved 7 July 2017.
  2. "加拿大勋章：提名争议骤掀波澜". GCP News. 14 July 2008. Retrieved 7 July 2017.
  3. Griffin, Kevin (27 May 2017). "Canada 150: Dr. Victor Ling made a huge breakthrough in fighting drug-resistant cancers". Vancouver Sun. Retrieved 7 July 2017.
  4. Order of Canada citation



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.